Skip to main content
Jason Foster, MD, General Surgery, Omaha, NE

JasonMarcellFosterMD

General Surgery • Omaha, NE

Surgical Oncology (Other than Breast)

Associate Professor, Surgery, University of Nebraska Medical Center College of Medicine

Join to view full profile

Are you Dr. Foster?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 76 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    601 N 30th St Ste 2803
    Omaha, NE 68131
    Phone+1 402-280-4100
    Fax+1 402-552-2512

Summary

  • Dr. Jason Foster, MD is a general surgeon in Omaha, Nebraska. He is currently licensed to practice medicine in Nebraska, New York, and Ohio. He is affiliated with Nebraska Medicine - Nebraska Medical Center and is an Associate Professor at University of Nebraska Medical Center College of Medicine.

Education & Training

  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Surgery, 1994 - 2002
  • Lewis Katz School of Medicine at Temple University
    Lewis Katz School of Medicine at Temple UniversityClass of 1994

Certifications & Licensure

  • NE State Medical License
    NE State Medical License 2005 - 2026
  • NY State Medical License
    NY State Medical License 2002 - 2007
  • OH State Medical License
    OH State Medical License 1996 - 2005
  • American Board of Surgery Surgery

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Fellow American College of Surgeons

Publications & Presentations

PubMed

Press Mentions

  • Surgery/HIPEC Safer Than Other High-Risk Cancer Procedures
    Surgery/HIPEC Safer Than Other High-Risk Cancer ProceduresJanuary 15th, 2019
  • Morbidity and Mortality Rates Following Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy Compared with Other High-Risk Surgical Oncology Procedures
    Morbidity and Mortality Rates Following Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy Compared with Other High-Risk Surgical Oncology ProceduresJanuary 4th, 2019

Professional Memberships

Dr. Jason Foster, Dr. Jason Foster, MD, Dr. J Foster, Dr. Jason Marcell Foster